Diakonos

Provider of immunotherapeutics for cancer treatment

placeHouston, Texas, United States calendar_todayFounded 2022 language diakonosoncology.com

Social engagement

Social engagement: 2.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Restem.

Investor typeCountShare
Venture capital120%
Private equity120%
Other / undisclosed360%

Recent activity

16 Jun 2026
Milestone
regulatory
2 Jun 2026
Partnership
Natera
6 May 2026
Milestone
regulatory
Coming soon